Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma

Infectious Agents and Cancer

Volumn 10, Issue 1, 2015, Pages

  Santoro, Angela ^a   Pannone, Giuseppe ^b   Ninivaggi, Rossella ^c   Petruzzi, Massimo ^c   Santarelli, Andrea ^d   Russo, Giuseppe Maria ^b   Lepore, Silvia ^e   Pietrafesa, Michele ^e   Laurenzana, Ilaria ^e   Leonardi, Rosalia ^f   Bucci, Paolo ^g   Natalicchio, Maria Iole ^h   Lucchese, Alberta ⁱ   Papagerakis, Silvana ^j   Bufo, Pantaleo ^b  

^a UCSC   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h Azienda Ospedali Riuniti   (Italy)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

^j UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

Cytokeratins; HR HPV; Immunohistochemistry

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; KERATINOCYTE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

EID: 84950142381     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/s13027-015-0041-x     Document Type: Article

References (64)

1. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9. doi: 10.1200/JCO.2007.14.1713. PMID:18235120.
2. Syrjänen KJ, Pyrhönen S, Syrjänen SM, Lamberg MA. Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Brit J Oral Surg. 1983;21(2):147-53. doi: 10.1016/0007-117X(83)90060-4.
3. Thompson IO, van der Bijl P, van Wyk CW, van Eyk AD. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol. 2001;46(12):1091-8. doi: 10.1016/S0003-9969(01)00082-6.
4. Shin KH, Min BM, Cherrick HM, Park NH. Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog. 1994;9(2):76-86. doi: 10.1002/mc.2940090205. PMid:8142012.
5. Zur Hausen H, de Villiers EM, Gissmann L. Papillomavirus infections and human genital cancer. Gynecol Oncol. 1981;12(2 pat1):S124-8. doi: 10.1016/0090-8258(81)90067-6.
6. Bosch FX, Lorincz A, Mu-oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-65. doi: 10.1136/jcp.55.4.244. PMid:11919208.
7. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(6):622-35. doi: 10.1067/moe.2001.115392.
8. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-9. doi: 10.1016/j.virol.2010.02.002. PMCid: PMC3400342.
9. Campisi G, Giovannelli L. Commentary: controversies surrounding human papillomavirus infection, head & neck vs oral cancer, implication for prophylaxis and treatment. Head Neck Oncol. 2009;1:8. doi: 10.1186/1758-3284-1-8PMid:19331691.
10. Mu-oz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27. doi: 10.1056/NEJMoa021641.
11. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents. Lyon, France: IARC; 2009. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100B). Chapter 6, Human papillomaviruses, pp. 255-313. Available from: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2009). A Review of Human Carcinogens. Part B: Biological Agents. Lyon, France: IARC. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100B). Chapter 6, Human papillomaviruses, pp. 255-313. Available from: http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-11.pdf.
12. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - Part B: Biological agents. Lancet Oncol Apr. 2009;10(4):321-2. PMid: 19350698.
13. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75. PMid: 15734974.
14. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008;19(10):1681-90. doi: 10.1093/annonc/mdn372 PMid: 18558666.
15. Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol. 2003;192(3):123-8. doi: 10.1007/s00430-002-0173-7. PMid:12920585.
16. Goon PKC, Stanley MA, Ebmeyer J, Steinsträsser L, Upile T, Jerjes W, et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009;1:36. doi: 10.1186/1758-3284-1-36 PMid:19828033 PMCid:PMC2770444.
17. Zehbe I, Ciccolini F, Dell'Orco M, De Pasquale C, Zaccaro F, Albarani V, et al. E7 protein of human papillomaviruses and its interaction with cellular pathways. In: Bannasch P, Kanduc D, Papa S, Tager JM, editors. Book Title: Cell growth and oncogenesis. Publisher: Birkhäuser Basel Verlag; 1998. p. 97-107. doi: 10.1007/978-3-0348-8950-6-7.
18. Cullen AP, Reid R, Campion M, Lörincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606-12. PMid:1846186.
19. Durst St M, Kleinheinz A, Hotz M, Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 1985;66:1515-22. doi: 10.1099/0022-1317-66-7-1515. PMid:2991428.
20. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer. 1992;51(6):845-50. doi: 10.1002/ijc.2910510602.
21. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002;102(2):152-8. doi: 10.1002/ijc.10669.
22. Sun Q, Tsutsumi K, Yokoyama M, Pater MM, Pater A. In vivo cytokeratin-expression pattern of stratified squamous epithelium from human papillomavirus-type-16-immortalized ectocervical and foreskin keratinocytes. Int J Cancer. 1993;54(4):656-62. doi: 10.1002/ijc.2910540422.
23. Staquet MJ, Viac J, Thivolet J. Keratin polypeptide modifications induced by Papillomaviruses (HPV). Arch Dermatol Res. 1981;271(1):83-90. doi: 10.1007/BF00417391.
24. Syrjänen S, Cintorino M, Armellini D, Del Vecchio MT, Leoncini P, Bugnoli M, et al. Expression of cytokeratin polypeptides in human papillomavirus (HPV) lesions of the uterine cervix: 1. Relationship to grade of CIN and HPV type. Int J Gynecol Pathol. 1988;7(1):23-38. PMID:2450850.
25. Franke WW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. J Cell Biol. 1979;81(3):570-80. doi: 10.1083/jcb.81.3.570. PMid:379021.
26. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11-24. doi: 10.1016/0092-8674(82)90400-7.
27. Kanaji N, Bandoh S, Fujita J, Ishii T, Ishida T, Kubo A. Compensation of type I and type II cytokeratin pools in lung cancer. Lung Cancer. 2007;55(3):295-302. doi: 10.1016/j.lungcan.2006.11.004. PMid:17161499.
28. Vaidya MM, Borges AM, Pradhan SA, Rajpal RM, BHisey AN. Altered keratin expression in buccal mucosal squamous cell carcinoma. J Oral Pathol Med. 1989;18(5):282-6. doi: 10.1111/j.1600-0714.1989.tb00398.x.
29. Lõning T, Staquet MJ, Thivolet J, Seifert G. Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol. 1980;388(3):273-88. doi: 10.1007/BF00430859.
30. Kellokoski J, Syrjänen S, Tosi P, Cintorino M, Leoncini P, Syrjänen K. Cytokeratin pattern in normal and HPV infected oral mucosa in women with genital HPV infections. J Oral Pathol Med. 1991;20(1):26-31. doi: 10.1111/j.1600-0714.1991.tb00883.x. PMid:1705981.
31. Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Anticancer Res. 1997;17(3C):2329-34. PMid:9245246.
32. Coltrera MD, Zarbo RJ, Sakr WA, Gown A. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol. 1992;141(4):817-25. PMid:1384338.
33. Tsubochi H, Suzuki T, Suzuki S, Ohashi Y, Ishibashi S, Moriya T, et al. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. Anticancer Res. 2000;20(2B):1205-11. PMid:10810423.
34. Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, et al. Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Gynecol Oncol. 1994;55(3):371-5. doi: 10.1006/gyno.1994.1309.
35. Nasu K, Etoh Y, Yoshimatsu J, Matsu T, Narahara H, Miyakawa I. Serum levels of cytokeratin 19 fragments in cervical cancer. Gynecol Obstet Invest. 1996;42:267-70. doi: 10.1159/000291978.
36. Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai M. Increased expression of cytokeratins 14, 18 and 19 correlates with tumor progression in the uterine cervix. Pathobiology. 1997;65:100-7. doi: 10.1159/000164110.
37. Babiker, Ali Yousif Yahia. Immunohistochemical and molecular detection of High Risk Human Papilloma Virus (HR-HPV), among Patients with Oral Lesions in Khartoum State. Sudan University of Science and Technology, College of Medical Laboratory Science PhD Thesis. 2014.
38. Barrett AW, Morgan M, Nwaeze G, Kramer G, Berkovitz BKB. The differentiation profile of the epithelium of the human lip. Arch of Oral Biol. 2005;50(4):431-8. doi: 10.1016/j.archoralbio.2004.09.012.
39. Babiker AY, Rahmani AH, Abdalaziz MS, Albutti A, Aly SM, Ahmed HG. Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients. Int J Clin Exp Med. 2014;7(6):1524-30. PMid:25035775 PMCid:PMC4100961.
40. Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, et al. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006;6:10. doi: 10.1186/1471-2407-6-10 PMid:16412231 PMCid:PMC1379654.
41. Safadi RA, Musleh AS, Al-Khateeb TH, Hamasha AA. Analysis of immunohistochemical expression of K19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method. Head Neck Oncol. 2010;4(4):282-9. http://dx.doi.org/10.1007/s12105-010-0210-6 PMid:20882374.
42. Ahmed AAM, Sanhour K, Gad Elkarim Ahmed H, Alamin R, Omer HE, Idris AM, et al. Expression of EGFR, CK5 and CK19 in oral squamous cell carcinoma tissues from Sudanese patients. IJBRITISH. 2014;1(4):71-5. ISSN 2349-9419.
43. Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 1980;19(4):1033-42. doi: 10.1016/0092-8674(80)90094-X.
44. Lyndeberg K, Rhenwald J. Suprabasal 40kDa keratin (K19) expression as immunologic marker of premalignancy in oral epithelium. Am J Pathol. 1989;134(1):89-98. PMCID: PMC1879556.
45. Leoncini P, Petracca R, Ruggiero P, Cintorino M, Syrjänen S, Mäntyjärvi R, et al. Expression of Cytokeratin No. 19 polypeptide in genital papillomavirus lesions. Gynecol obstet Invest. 1990;29:59-66. doi: 10.1159/000293302. PMid:1693587.
46. Taichman LB, Reilly SS, La Porta RF. The role of keratinocyte differentiation in the expression of epitheliotropic viruses. J Invest dermatol. 1983;81(s1):137-40. doi: 10.1111/1523-1747.ep12540909.
47. Favia G, Kanduc D, Lo Muzio L, Lucchese A, Serpico R. Possible association between HPV16 E7 protein level and cytokeratin 19. Int J Cancer. 2004;111(5):795-7. doi: 10.1002/ijc.20343.
48. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha1-globin and human cytokeratin 7. J Virol. 2002;76(14):7040-8. doi: 10.1128/JVI.76.14.7040-7048.2002.
49. Gillespie MB, Rubinchik S, Hoel B, Sutkowski N. Human papillomavirus and oropharyngeal cancer: what you need to know in 2009. Curr Treat Options Oncol. 2009;10(5-6):296-307. doi: 10.1007/s11864-009-0113-5. PMid:19768554.
50. Peixoto T, Castro PG, Bussoloti Filho I. Prevalence of human papillomavirus (HPV) in oral cavity and in oropharynx. Rev Bras Otorinolaringol. 2006;72(2):272-82. doi: 10.1590/S0034-72992006000200021.
51. Scapoli L, Palmieri A, Rubini C, Martinelli M, Spinelli G, Ionna F, et al. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol. 2009;22(3):366-72. doi: 10.1038/modpathol.2008.180.
52. Grønhøj Larsen C, Gyldenløve M, Jensen DH, Therkildsen MH, Kiss K, Norrild B, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110(6):1587-94. doi: 10.1038/bjc.2014.42 PMCid: PMC3960616.
53. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6 PMid: 20451455.
54. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96(13):998-1006. PMid: 15240783.
55. Morshed K, Polz-Dacewicz M, Szymajski M, Dorota P. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol. 2008;265 Suppl 1:S89-96. doi: 10.1007/s00405-007-0569-5. PMid:18193443 PMCid:PMC2441493.
56. Eklund C, Zhou T, Dillner J. The WHOHPV LabNet international proficiency study of HPV typing methods. The 25th International Papillomavirus Conference: 8-14th May 2009 2009; Malmö, Sweden 2009.
57. Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007;67(10):4605-19. doi: 10.1158/0008-5472.CAN-06-3619. PMid:17510386.
58. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(3 Pt1):701-9. doi: 10.1158/1078-0432.CCR-05-2017.
59. Pannone G, Rodolico V, Santoro A, Lo Muzio L, Franco R, Botti G, et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer. 2012;7:4. doi: 10.1186/1750-9378-7-4.
60. Pannone G, Santoro A, Papagerakis S, Lo Muzio L, De Rosa G, Bufo P. The role of Human Papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer. 2011;6:4. doi: 10.1186/1750-9378-6-4. PMID:21447181 PMCID:PMC30723253.
61. Pannone G, Santoro A, Carinci F, Bufo P, Papagerakis SM, Rubini C, et al. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. Int J Immunopathol Pharmacol. 2011;24(Suppl2):95-101. PMid:21781453.
62. American Joint Committee on Cancer. Exocrine pancreas. In: Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual. 6th ed. NY, USA: Springer; 2002. p. 157-64. (ISBN 0-387-95271-3) doi: 10.1007/978-1-4757-3656-4-18.
63. Epstude J, Müller P, Hyckel P, Schumann D. Qualitative and quantitative studies of the inflammatory reaction in the tumor boundary zone of intraoral squamous cell carcinomas. Dtsch Zahn Mund Kieferheilkd Zentralbl. 1991;79(6):483-9. PMid:1932438.
64. Husnjak K, Grce M, Magdić L, Pavelić K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods. 2000;88(2):125-34. doi: 10.1016/S0166-0934(00)00194-4.